相关实验视频

Updated: May 24, 2025

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

NF基因疗法的不断变化的格局:障碍和机遇

Alexandra K O'Donohue^1,2, Samantha L Ginn³, Gaetan Burgio⁴

¹Bioengineering and Molecular Medicine Laboratory, The Children's Hospital at Westmead and Westmead Institute for Medical Research, Westmead, NSW 2145, Australia.

Molecular therapy. Nucleic acids

|March 4, 2025

概括

基因疗法为治疗神经纤维素瘤 (NF1和NF2),导致神经瘤的罕见遗传疾病提供了新的希望. 像基因编辑和向载体这样的新兴方法显示出治疗治疗的希望,解决NF的遗传原因.

科学领域:

遗传学和分子生物学
在瘤学瘤学.
神经学神经学

背景情况:

神经纤维素瘤类型1 (NF1) 和NF2相关的神经纤维素瘤是罕见的遗传性疾病.
这些条件使个人容易患上与神经相关的瘤.
目前的治疗方法管理症状,而不是潜在的遗传原因.

研究的目的:

审查NF1和NF2的基因疗法的进展.
探索针对这些疾病的遗传基础的潜在治愈治疗方法.
确定基因疗法的临床采用所面临的挑战.

主要方法:

对基因疗法方法的临床前数据的审查.
对基因疗法载体开发进展的分析.
对NF瘤的基因添加和修复策略的讨论.

主要成果:

无稽之谈抑制剂和寡核酸疗法显示出临床前的前景.
基因治疗载体正在开发用于局部瘤切除.
基因添加和修复策略为NF瘤预防和治疗提供了潜力.

结论:

基因疗法为治疗NF1和NF2提供了一个有希望的途径.
针对施万细胞的向输送载体对于治疗成功至关重要.
需要进一步开发以克服临床应用的障碍.

关键词:

MT:RNA/DNA编辑编辑没有NF,没有NF.基因编辑基因编辑基因治疗的基因疗法这是神经纤维素瘤.病毒载体病毒载体

更多相关视频

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA

Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA

Published on: June 25, 2014

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

What is Genetic Engineering?

What is Genetic Engineering?